E.P.T.Q. was born for women who want to manage beauty’s exquisite detail. The hyaluronic acid filler e.p.t.q. produced according to technology and process of JETEMA R&D center promises an exquisite and safe quality.
DESCRIPTION OF THE PRODUCT
E.P.T.Q. (epitique) means “exquisite” + “technique”
E.P.T.Q. will show you the exquisite technology to express the ideal beauty
– safe with Minimized MOD Level of 1% through low BDDE
– high cohesiveness for excellent molding
– homogenous particle size for exquisite molding
– minimized endotoxin level and calficiation that may cause initial side effects
Package information: 1 pre-filled syringe (1.0mL)*2 needles of 27G
HA Concentration: 24mg/ml
TECHNICAL DETAILS
For Face:
– S100 – for Superficial to Mid Dermis
– S300 – for Mid to Deep Dermis
– S500 – for Subcutaneous area
– S100L (with 0.3% lidocaine)
– S300L (with 0.3% lidocaine)
– S500L (with 0.3% lidocaine)
For Body:
– S500 – 3 pre-filled syringes with 3.0cc/package
What is hyaluronic acid filler?
Injectable hyaluronic acid (HA) is a type of temporary dermal filler. Injectable HA is used to reduce the appearance of fine lines and wrinkles, facial folds, and to create structure, framework, and volume to the face and lips. The effects of injectable hyaluronic acid are seen immediately. This is a transparent, odorless, hydrophilic gel, maintained by water.
Ministry of Food & Drug Safety in Korea approves E.P.T.Q. (epitique) as a biomedical material for correction of facial wrinkles in adults.
Crosslinking Level | Gel Texture | Concentration | Needles | Injection Depth | Duration | |
e.p.t.q. S100 | ● ○ ○ | ![]() | HA 24 mg/ml | 27 G | Superficial / Mid Dermis | 24 Months |
e.p.t.q. S100 lidocaine | ● ○ ○ | ![]() | HA 24 mg/ml Lidocaine 0,3% | 27 G | Superficial / Mid Dermis | 24 Months |
e.p.t.q. S300 | ● ● ○ | ![]() | HA 24 mg/ml | 27 G | Mid / Deep Dermis | 24 Months |
e.p.t.q. S300 lidocaine | ● ● ○ | ![]() | HA 24 mg/ml Lidocaine 0,3% | 27 G | Mid / Deep Dermis | 24 Months |
e.p.t.q. S500 | ● ● ● | ![]() | HA 24 mg/ml | 27 G | Subcutaneous / Supraperiosteal areas | 24 Months |
e.p.t.q. S500 lidocaine | ● ● ● | ![]() | HA 24 mg/ml Lidocaine 0,3% | 27 G | Subcutaneous / Supraperiosteal areas | 24 Months |